Deep tissue cancers, also known as sarcomas, are not as common as carcinomas and consequently less basic research has been resolved on the causes and medical treatments investigated on sarcomas.
A series of laboratory molecular experiments resulted in narrowing down more than 2,000 possible targets for pharmaceutical treatment of sarcomas.
Scientists conclude that these cancers born from fat or muscle are most likely to share 39 common proteins.
Ask your oncologist about clinical trials available to you.
Identifying which molecular...